RP

Rupesh Prakashrao Gundawar

Active Director Designated Partner DIN 08554397
DIN 08554397 First appointment Sep 2019 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Rupesh Prakashrao Gundawar

Data last updated:

Rupesh Prakashrao Gundawar is a Designated Partner at Krishna Surgical Pathology Llp (since 2019). The company operates in Healthcare.

DIN 08554397
Primary Designation Designated Partner
Industry Healthcare
First Appointment 04 Sep 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Sep 20192019Active

Board colleagues of Rupesh Prakashrao Gundawar

NameDINCompanyDesignation
Rujuta Sanjay Ayachit08554398Krishna Surgical Pathology LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Krishna Surgical Pathology Llp
Premium access

Shareholding and investment profile for Rupesh Prakashrao Gundawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupesh Prakashrao Gundawar

Rupesh Prakashrao Gundawar currently holds 1 directorship: Krishna Surgical Pathology Llp (Designated Partner, since 04 Sep 2019).

Rupesh Prakashrao Gundawar was first appointed on 04 Sep 2019 as Designated Partner at Krishna Surgical Pathology Llp.

The current boards of Rupesh Prakashrao Gundawar's companies include Rujuta Sanjay Ayachit (Krishna Surgical Pathology Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available